将 B 细胞与浆细胞靶向从肿瘤学转化至自身免疫:模式、定量桥接与开发路线图 Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap. PubMed 2026/06/05 发表Clin Pharmacol TherQ1 · IF 4.9(JCR 2025) 靶点:CD19靶点:CD20靶点:CD38技术:双特异性抗体淋巴瘤骨髓瘤
SOHO 前沿进展与待解问题|惰性 B 细胞淋巴瘤治疗的新型免疫联合方案 SOHO State of the Art Updates and Next Questions | Novel Immunotherapy Combinations for the Treatment of Indolent B-Cell Lymphoma. PubMed 2025/01/28 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1(JCR 2025) 靶点:CD19靶点:CD20技术:双特异性抗体B细胞淋巴瘤白血病骨髓瘤
使用无柱流式装置富集 CD4(+) 和 CD8(+) T 淋巴细胞用于临床细胞生产 Enrichment of CD4(+) and CD8(+) T lymphocytes with a column-free flow-based device for clinical cell manufacturing. PubMed 2025/01/02 发表CytotherapyQ1 · IF 4.5(JCR 2025) 靶点:CD19靶点:CD20技术:CAR-T非霍奇金淋巴瘤多发性骨髓瘤白血病
多剂 SARS-CoV-2 疫苗在接受 CAR-T 细胞治疗的 B 细胞血液系统恶性肿瘤患者中的疗效:一项当代队列分析 Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A C PubMed 2023/12/23 发表Transplant Cell TherQ1 · IF 4.7(JCR 2025) 靶点:CD19靶点:CD20靶点:BCMA技术:CAR-T多发性骨髓瘤地区:美国
血液肿瘤双特异性单克隆抗体研究进展 Update on bi-specific monoclonal antibodies for blood cancers. PubMed 2023/07/05 发表Curr Opin OncolQ3 · IF 2.4(JCR 2025) 靶点:CD20技术:CAR-T技术:双特异性抗体弥漫大B细胞淋巴瘤滤泡性淋巴瘤多发性骨髓瘤
SOHO 最前沿更新与后续问题:华氏巨球蛋白血症——2021 年治疗进展与未来方向 SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions. PubMed 2021/11/26 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1(JCR 2025) 靶点:CD20技术:CAR-T技术:双特异性抗体华氏巨球蛋白血症淋巴瘤白血病
复发/难治性弥漫大 B 细胞淋巴瘤的新型治疗格局 The Novel Therapeutic Landscape for Relapsed/Refractory Diffuse Large B Cell Lymphoma. PubMed 2021/11/20 发表Clin Lymphoma Myeloma LeukQ1 · IF 4.1(JCR 2025) 人群:成人靶点:CD19靶点:CD20靶点:CD22技术:CAR-T技术:双特异性抗体